To the Editor:
Handling over 100 million COVID-19 cases, frontline medical personnel are threatened due to the high risk of cross-infection. Several studies have recommended that medical personnel with suspicious symptoms (including fever, cough, diarrhea, muscle pain, and loss of smell) clearly receive SARS-CoV-2 testing and at least 14 days of quarantine (close contact with COVID-19 patients without appropriate infection prevention) [
1]. Lacking personnel would slow down the hospital operation and further impact patient safety. Notably, we agree that COVID-19 should be excluded first. However, early identification of “non-COVID-19” pathogens would also be beneficial for adjusting the length of quarantine and the policy of workforce resupply. For example, medical personnel with rhinovirus infection might not need 14-day quarantine. Unfortunately, information regarding non-COVID-19 pathogens (including coinfections) among frontline medical personnel is not well known, and we aim to present our experience in Taiwan.
From 1 March to 30 June 2020, a total of 1272 patients were reported to the Taiwan CDC for testing COVID-19 (SARS-CoV-2) in our hospital. Among them, 115 (9%) were frontline medical personnel (handling or facing patients). In addition, 105 of them (91.3%) received rapid respiratory panel test (BIOFIRE® FILMARRAY® Respiratory Panels) in the emergency department (ED) (Table
1). All of them were negative for COVID-19. However, 26 (24.7%) of them tested positive for non-COVID pathogens, including 18 (17.1%) who were positive for human rhinovirus/enterovirus RNA, 2 (1.9 %) who were positive for coronavirus OC43 RNA, and 2 (1.9%) who were positive for coronavirus NL63 RNA (Table
2). Three (2.9%) patients had coinfections (2 or > 2 categories of virus). The first was coinfected with coronavirus OC43 RNA and human rhinovirus/enterovirus RNA, the second was coinfected with adenovirus DNA and human rhinovirus/enterovirus RNA, and the last was coinfected with parainfluenza virus 4 RNA and respiratory syncytial virus RNA.
Table 1
Demographics of patients who received non-COVID-19 pathogen examinations
Sex |
Male | 19 (18.1%) |
Female | 86 (81.9%) |
Age (years) |
< 31 | 43 (41.0%) |
31–40 | 40 (38.1%) |
41–50 | 18 (17.1%) |
51–60 | 4 (3.8%) |
Table 2
Categories of pathogens of 105 patients who received non-COVID-19 pathogen examinations
Rhinovirus/enterovirus RNA | 18 (17.1%) |
Coronavirus OC43 RNA | 2 (1.9%) |
Coronavirus NL63 RNA | 2 (1.9%) |
Adenovirus DNA | 2 (1.9%) |
Parainfluenza virus 4 | 2 (1.9%) |
Respiratory syncytial virus RNA | 1 (1.0%) |
Coronavirus HKU1 RNA | 1 (1.0%) |
Among the medical personnel (with suspected symptoms), our results demonstrated that 24.7% tested positive for non-COVID pathogens. Rhinoviruses and enteroviruses were the leading non-COVID-19 pathogens during the pandemic period. When facing workforce insufficiency, long-term quarantine for medical personnel might not be necessary when their COVID-19 and non-COVID-19 pathogens are both confirmed early. In one testing model, the chance of post-quarantine transmission might obviously decrease after 7 days of quarantine [
2]. A rapid respiratory panel test in the ED might be effective for early detection. Finally, we recommend that the quarantine period should be at least 7 days for (suspected symptoms) medical personnel who are negative for all pathogens (including COVID-19 and FILMARRAY Respiratory Panels).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.